Insider · CIK 0001707797

Jain Rita

Reports to the SEC for 9 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001707797

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,322 sh	$12.29	+$16.2K	1,322
2026-06-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,080 sh	$15.04	+$16.2K	1,080
2026-06-25	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
2026-06-15	TRAXFirst Tracks Biotherapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,330 sh	—	—	19,194
2026-06-15	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,030 sh	—	—	0
2026-06-15	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,300 sh	—	—	0
2026-06-02	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.1K sh	—	—	20,100
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42K sh	—	—	42,000
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+2,500 sh	—	—	2,500
2026-05-12	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+15K sh	—	—	15,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.6K sh	—	—	10,600
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,015 sh	—	—	8,015
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+6,030 sh	—	—	6,030
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+4,000 sh	—	—	4,000
2026-04-20	TRAXFirst Tracks Biotherapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+1,300 sh	—	—	1,300
2026-03-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,339 sh	$12.13	+$16.2K	1,339
2026-01-06	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2026-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+4,000 sh	—	—	4,000
2026-01-05	SABSSAB Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+240K sh	—	—	240,000
2025-12-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,043 sh	$14.74	+$15.4K	1,043
2025-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,572 sh	—	—	1,572
2025-06-17	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,200
2025-06-15	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,300 sh	—	—	1,300
2025-06-15	ANABANAPTYSBIO, INCM Exercise/Conversion	Director	MExercise/Conversion	+7,330 sh	—	—	11,864
2025-06-15	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,030 sh	—	—	0
2025-06-05	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2025-01-07	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2025-01-07	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+6,030 sh	—	—	6,030
2024-06-15	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,300 sh	—	—	0
2024-06-15	ANABANAPTYSBIO, INCM Exercise/Conversion	Director	MExercise/Conversion	+4,534 sh	—	—	4,534
2024-06-15	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,234 sh	—	—	0
2024-06-13	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2024-01-03	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+6,030 sh	—	—	6,030
2024-01-03	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,510
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−66K sh	—	—	0
2023-04-03	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+10.6K sh	—	—	10,600
2023-04-03	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	Director	AAward	+8,015 sh	—	—	8,015
2023-04-03	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+3,900 sh	—	—	3,900
2023-04-03	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+3,234 sh	—	—	3,234
2023-02-16	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.1K sh	—	—	17,100
2023-01-03	Provention Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+66K sh	—	—	66,000
2022-10-20	ChemoCentryx, Inc.Restricted Stock UnitD Disposition to Issuer	Director, EVP, Chief Medical Officer	DDisposition to Issuer	−11.6K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.D Disposition to Issuer	Director, EVP, Chief Medical Officer	DDisposition to Issuer	−35.9K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, EVP, Chief Medical Officer	DDisposition to Issuer	−307 sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, EVP, Chief Medical Officer	DDisposition to Issuer	−14.4K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, EVP, Chief Medical Officer	DDisposition to Issuer	−21.1K sh	—	—	0

Recent filings

Accepted (ET)
Oct 24
Jain Rita0001707797-26-000017
SEC(opens sec.gov)
Jul 24
Jain Rita0001707797-26-000014
SEC(opens sec.gov)
Jun 294
Jain Rita0001707797-26-000012
SEC(opens sec.gov)
Jun 174
Jain Rita0001707797-26-000010
SEC(opens sec.gov)
Jun 124/A
Jain Rita0001707797-26-000009
SEC(opens sec.gov)
Jun 44
Jain Rita0001707797-26-000008
SEC(opens sec.gov)
May 144
Jain Rita0001707797-26-000006
SEC(opens sec.gov)
Apr 224
Jain Rita0001707797-26-000005
SEC(opens sec.gov)
Apr 14
Jain Rita0001707797-26-000003
SEC(opens sec.gov)

Companies

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087